505 results on '"Kagawa, Naoki"'
Search Results
52. MEDB-30. Subclassification of Group 3/4 medulloblastoma as a potential prognostic biomarker to reduce the dose of craniospinal irradiation in patients with metastatic tumors: A Japanese Pediatric Molecular Neuro-Oncology Group study
53. Radiofrequency ablation of early breast cancer followed by delayed surgical resection – A promising alternative to breast-conserving surgery
54. O1-6-1 - Tolerability and pharmacokinetics (PK) of ABT-414 in Japanese patients (pts) with malignant glioma
55. Vortex Lattice Melting in Underdoped YBa2Cu4O8
56. Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting MGMT promoter methylation and prognostic value in newly diagnosed patients with glioblastoma.
57. 11C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison
58. Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map
59. Identification of target antigens for chimeric antigen receptor T-cell therapy against glioblastoma using a monoclonal antibody library raised against patient-derived tumor spheres
60. Prognostic significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18 Gray of craniospinal irradiation
61. Improvement of beam-tracker for sensor network with Free Space Optics
62. TB-9 An attempt to establish a patient-derived brain tumor culture model by organoid culture method
63. MPC-6 Clinical significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18Gy of craniospinal irradiation
64. IM-7 Identification of novel glioblastoma specific antigen using patient derived tumor cell for CAR-T cell therapy
65. NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
66. COT-16 Development of automatic lesion extraction application using artificial intelligence for the purpose of simplifying tumor volume measurement of meningioma
67. How Much Tumor Volume Is Responsible for Development of Clinical Symptoms in Patients With Convexity, Parasagittal, and Falx Meningiomas?
68. Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma
69. Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.
70. Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial
71. Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials
72. Determination of brain tumor recurrence using 11 C‐methionine positron emission tomography after radiotherapy
73. Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis
74. Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography
75. Imaging 18F-fluorodeoxy glucose/11C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema
76. A survey of disclosure of diagnosis to patients with glioma in Japan
77. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors
78. A rare case of a simultaneously detected suprasellar and intramedullary spinal cord germinoma
79. Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy
80. A surgically treated case of Lhermitte–Duclos disease with a precise natural history and high uptake of FDG on PET
81. Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients
82. Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema
83. Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy
84. Determination of brain tumor recurrence using C-11-methionine positron emission tomography after radiotherapy
85. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays
86. Scoring radiologic characteristics to predict proliferative potential in meningiomas
87. Ganglioside GM3 inhibits proliferation and invasion of glioma
88. Efficacy of endovascular intratumoral embolization for meningioma: assessment using dynamic susceptibility contrast-enhanced perfusion-weighted imaging
89. Successful neurosurgical separation of conjoined spinal cords in pygopagus twins: illustrative cases
90. Chromosomal and genetic aberrations differ with meningioma subtype
91. Genetic analysis of human glioblastomas using a genomic microarray system
92. Hypofractionated Stereotactic Radiation Therapy in Three to Five Fractions for Vestibular Schwannoma
93. 11C-methionine uptake and intraoperative 5-aminolevulinic acid-induced fluorescence as separate index markers of cell density in glioma: A stereotactic image-histological analysis
94. Biased usage of T cell receptor β-chain variable region genes of Wilmsʼ tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors
95. Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
96. Development of Beam-tracking for Movable Sensor Network with Free Space Optics
97. Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
98. Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging—A controversy
99. The Exoscope Paradigm Shift in Neurosurgery
100. Electric vehicle utilizing PMV auxiliary parts (in-wheel motor)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.